14,15-EET analogs: Characterization of structural requirements for agonist and antagonist activity in bovine coronary arteries

Pharmacological Research

Volumn 49, Issue 6, 2004, Pages 515-524

  Gauthier, Kathryn M ^a   Falck, J R ^b   Reddy, L Manmohan ^b   Campbell, William B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

EDHF; Endothelium; Epoxyeicosatrienoic acid; Vascular relaxation

Indexed keywords

14,15 EPOXY 5,8,11 ICOSATRIENOIC ACID; EPOXIDE; EPOXYICOSATRIENOIC ACID; POTASSIUM CHANNEL;

BLOOD VESSEL TONE; CATTLE; CHEMICAL BOND; CORONARY ARTERY; DRUG ACTIVITY; DRUG STRUCTURE; ENZYME ACTIVITY; HYPERPOLARIZATION; ISOMER; METABOLITE; MOLECULE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE; VASCULAR ENDOTHELIUM;

EID: 1542512379     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phrs.2003.09.014     Document Type: Article

References (55)

1. Rosolowsky M., Campbell W.B. Synthesis of hydroxyeicosatetraenoic acids (HETEs) and epoxyeicosatrienoic acids (EETs) by cultured bovine coronary artery endothelial cells. Biochim. Biophys. Acta. 1299:1996;267-277.
2. Lin J.H.-C., Kobari Y., Zhu Y., Stemerman M.B., Pritchard K.A. Human umbilical vein endothelial cells express P450 2C8 mRNA: cloning of endothelial P450 epoxygenase. Endothelium. 4:1996;219-229.
3. Fisslthaler B., Popp R., Kiss L., Potente M., Harder D.R., Fleming I.et al. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature. 401:1999;493-497.
4. Node K., Huo Y., Ruan X., Yang B., Spiecker M., Ley K.et al. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science. 285:1999;1276-1279.
5. Campbell W.B., Gebremedhin D., Pratt P.F., Harder D.R. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ. Res. 78:1996;415-423.
6. Fulton D., McGiff J.C., Quilley J. Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney. Br. J. Pharmacol. 107:1992;722-725.
7. Hecker M., Bara A.T., Bauersachs J., Busse R. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J. Physiol. 481:1994;407-414.
8. Pinto A., Abraham N.G., Mullane K.M. Arachidonic acid-induced endothelial-dependent relaxation of canine coronary arteries: contribution of a cytochrome P-450-dependent pathway. J. Pharmacol. Exp. Ther. 240:1987;856-863.
9. Fisslthaler B., Popp R., Michaelis R., Kiss L., Fleming I., Busse R. Cyclic stretch enhances the expression and activity of coronary endothelium-derived hyperpolarizing factor synthase. Hypertension. 38:2001;1427-1432.
10. + channels in porcine coronary artery smooth muscle cells. J. Cardiovasc. Pharmacol. 32:1998;642-649.
11. Li P.-L., Campbell W.B. Epoxyeicosatrienoic acids activate potassium channels in coronary smooth muscle through guanine nucleotide binding protein. Circ. Res. 80:1997;877-884.
12. Ca channels expressed in human embryonic kidney 293 cells by epoxyeicosatrienoic acid. Molec. Pharmacol. 59:2001;16-23.
13. Li P.-L., Chen C.-L., Bortell R., Campbell W.B. 11,12- Epoxyeicosatrienoic acid stimulates endogenous mono-ADP-ribosylation in bovine coronary arterial smooth muscle. Circ. Res. 85:1999;349-356.
14. Ca channels in coronary arterial smooth muscle cells. Am. J. Physiol. 282:2002;H1229-H1236.
15. 2 and EETs in the relaxation of bovine coronary arteries to arachidonic acid. Am. J. Physiol. 264:1993;H327-H335.
16. Rosolowsky M., Falck J.R., Willerson J.T., Campbell W.B. Synthesis of lipoxygenase and epoxygenase products of arachidonic acid by normal and stenosed canine coronary arteries. Circ. Res. 66:1990;608-621.
17. Carroll M.A., Schwartzman M., Capdevila J., Falck J.R., McGiff J.C. Vasoactivity of arachidonic acid epoxides. Eur. J. Pharmacol. 138:1987;281-283.
18. Ellis E.F., Police R.J., Yancy L., McKinney J.S., Amruthesh S.C. Dilation of cerebral arterioles by cytochrome P-450 metabolites of arachidonic acid. Am. J. Physiol. 259:1990;H1171-H1177.
19. Leffler C.W., Fedinec A.L. Newborn piglet cerebral microvascular responses to epoxyeicosatrienoic acids. Am. J. Physiol. 273:1997;H333-H338.
20. 450 monooxygenase. Circ. Res. 60:1987;50-59.
21. Weintraub N.L., Fang X., Kaduce T.L., VanRollins M., Chatterjee P., Spector A.A. Epoxide hydrolase regulates epoxyeicosatrienoic acid incorporation into coronary endothelial phospholipids. Am. J. Physiol. 277:1999;H-2108.
22. Zeldin D.C., Kobayashi J., Falck J.R., Winder B.S., Hammock B.D., Snapper J.R.et al. Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase. J. Biol. Chem. 268:1993;6402-6407.
23. Oltman C.L., Weintraub N.L., VanRollins M., Dellsperger K.C. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation. Circ. Res. 83:1998;932-939.
24. Weintraub N.L., Fang X., Kaduce T.L., VanRollins M., Chatterjee P., Spector A.A. Potentiation of endothelium-dependent relaxation by epoxyeicosatrienoic acids. Circ. Res. 81:1997;258-267.
25. Ca channels. Am. J. Physiol. 282:2002;H1656-H1664.
26. Harder D.R., Gebremedhin D., Narayanan J., Jefcoat C., Falck J.R., Campbell W.B.et al. Formation and action of a P-450 4A metabolite of arachidonic acid in cat cerebral microvessels. Am. J. Physiol. 266:1994;H2098-H2107.
27. Gebremedhin D., Lange A.R., Lowry T.F., Taheri M.R., Birks E.K., Hudetz A.G.et al. Production of 20-HETE and its role in autoregulation of cerebral blood flow. Circ. Res. 87:2000;60-65.
28. Ma Y.-H., Gebremedhin D., Schwartzman M.L., Falck J.R., Clark J.E., Masters B.S.et al. 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ. Res. 72:1993;126-136.
29. Kauser K., Clark J.E., Masters B.S., Ortiz de Montellano P.R., Ma Y.-H., Harder D.R.et al. Inhibitors of cytochrome P-450 attenuate the myogenic response of dog renal arcuate arteries. Circ. Res. 68:1991;1154-1163.
30. +-channel activity. Am. J. Physiol. 270:1996;F822-F832.
31. Wong P.Y.-K., Lai P.-S., Falck J.R. Mechanism and signal transduction of 14(R), 15(S)-epoxyeicosatrienoic acid (14,15-EET binding in guinea pig monocytes. Prostaglandins Other Lipid Mediat. 62:2000;321-333.
32. Corey E.J., Niwa H., Falck J.R. Selective epoxidation of eicosa-cis-5,8,11,14-tetraenoic (arachidonic) acid and eicosa-cis-8,11,14- trienoic acid. J. Am. Chem. Soc. 101:1979;586-587.
33. Fulton D., Falck J.R., McGiff J.C., Carroll M.A., Quilley J. A method for the determination of 5,6-EET using the lactone as an intermediate in the formation of the diol. J. Lipid Res. 39:1998;1713-1721.
34. Falck J.R., Manna S., Viala J., Siddhanta A.K. Arachidonate epoxygenase: inhibitors and metabolite analogues. Tetrahedron Lett. 26:1985;2287-2290.
35. Falck J.R., Yadagiri P., Capdevila J. Synthesis of epoxyeicosatrienoic acids and heteroatom analogs. Methods Enzymol. 187:1990;357-364.
36. Zeldin D.C., Shouzou W., Falck J.R., Hammock B.D., Snapper J.R., Capdevila J.H. Metabolism of epoxyeicosatrienoic acids by cytosolic epoxide hydrolase: substrate structural determinants of asymmetric catalysis. Arch. Biochem. Biophys. 316:1995;443-451.
37. Krishna U.M., Reddy M.M., Xia J., Falck J.R., Balazy M. Stereospecific synthesis of trans-arachidonic acids. Bioorg. Med. Chem. Lett. 11:2001;2415-2418.
38. Falck J.R., Kumar P.S., Reddy Y.K., Zou G., Capdevila J.H. Stereospecific synthesis of EET metabolites via Suzuki-Miyaura coupling. Tetrahedron Lett. 42:2001;7211-7212.
39. Chen J.K., Falck J.R., Reddy K.M., Capdevila J., Harris R.C. Epoxyeicosatrienoic acids and their sulfonimide derivatives stimulate tyrosine phosphorylation and induce mitogenesis in renal epithelial cells. J. Biol. Chem. 273:1998;29254-29261.
40. Falck J.R., Krishna U.M., Reddy Y.K., Kumar P.S., Reddy K.M., Hittner S.B.et al. Comparison of the vasodilatory properties of 14,15-EET analogs: structural requirements for dilation. Am. J. Physiol. 284:2003;H337-H349.
41. Gauthier K.M., Deeter C., Krishna U.M., Reddy Y.K., Bondlela M., Falck J.R.et al. 14,15-Epoxyeicosa-5(Z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries. Circ. Res. 90:2002;1028-1036.
42. Revtyak G.E., Johnson A.R., Campbell W.B. Cultured bovine coronary arterial endothelial cells synthesize HETEs and prostacyclin. Am. J. Physiol. 254:1988;C8-C19.
43. Backes B.J., Ellman J.A. Carbon-carbon bond-forming methods on solid support. Utilization of Kenner's "Safety-Catch" linker. J. Am. Chem. Soc. 116:1994;11171-11172.
44. Imig J.D., Falck J.R., Wei S., Capdevila J.H. Epoxygenase metabolites contribute to nitric oxide-independent afferent arteriolar vasodilation in response to bradykinin. J. Vasc. Res. 38:2001;247-255.
45. Snyder G.D., Krishna U.M., Falck J.R., Spector A.A. Evidence for a membrane site of action for 14,15-EET on expression of aromatase in vascular smooth muscle. Am. J. Physiol. 283:2002;H1936-H1942.
46. Kuhl W.E., Spector A.A. Uptake of long-chain fatty acid-methyl esters by mammalian cells. J. Lipid Res. 11:1970;458-465.
47. Spector A.A., Soboroff J.M. Long chain fatty acid methyl ester hydrolase activity in mammalian cells. Lipids. 7:1972;186-190.
48. VanRollins M., Kaduce T.L., Knapp H.R., Spector A.A. 14,15- Epoxyeicosatrienoic acid metabolism in endothelial cells. J. Lipid Res. 34:1993;1931-1942.
49. Fang X., Kaduce T.L., Weintraub N.L., VanRollins M., Spector A.A. Functional implications of a newly characterized pathway of 11,12- epoxyeicosatrienoic acid metabolism in arterial smooth muscle. Circ. Res. 79:1996;784-793.
50. Fang X., Weintraub N.L., Oltman C.L., Stoll L.L., Kaduce T.L., Harmon S.et al. Human coronary endothelial cells convert 14,15-EET to a biologically active chain-shortened epoxide. Am. J. Physiol. 283:2002;H2306-H2314.
51. Capdevila J.H., Falck J.R., Harris R.C. Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase. J. Lipid Res. 41:2000;163-181.
52. Lauterbach B., Barbosa-Sicard E., Wang M.H., Honeck H., Kargel E., Theuer J.et al. Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activators. Hypertension. 39:2002;609-613.
53. Zhang Y., Oltman C.L., Lu T., Lee H.C., Dellsperger K.C., VanRollins M. EET homologs potently dilate coronary microvessels and activate BK(Ca) channels. Am. J. Physiol. 280:2001;H2430-H2440.
54. Gauthier KM, Jagadeesh SD, Falck JR, Campbell WB. 14,15-Epoxyeicosa-5(Z)- enoic-methylsulfonylimide: an EET antagonist in coronary arteries. Hypertension 2003;42:555-61.
55. Nithipatikom K., Grall A.J., Holmes B.B., Harder D.R., Falck J.R., Campbell W.B. Liquid chromatographic-electrospray ionization mass spectrometric analysis of cytochrome P450 metabolites of arachidonic acid. Anal. Biochem. 298:2001;327-336.